Clinical Trials

A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications


Study ID
EMD Serono EMR 100070-001

NCT Number
NCT01772004 (Click on the NCT number for more information about the trial)

Research Study Number
00004517

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
EMD Serono


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now